Pharmacokinetics of ribavirin tablets in healthy volunteers
Jinguang Huang
Abstract
Jinguang Huang
Abstract
Objective To evaluate the safety and pharmacokinetic parameters of a domestic ribavirin tablets in Chinese healthy male volunteers after administered 300 mg oral dosage. Methods Twenty healthy Chinese volunteers were given a single oral dose domestic ribavirin tablet. The concentration of ribavirin in blood plasma was measured by an validated LC-MS/MS method and were assessed with non-compartment model to obtain the pharmacokinetic parameters.Results The pharmacokinetic parameters of ribavirin tablets for orally administered 300 mg dosage were as follows: AUC0-t was(5584.91±1659.34)ng.h.mL-1; AUC0-∞ was(7166.33±2224.28)ng.h.mL-1;Cmax was(442.60±148.97)ng.mL-1;tmax was(1.40±1.20)h;t1/2 was(22.93±6.38)h;Ke was (0.03±0.01) h-1;Vd was (1484.37±491.50);CL was (45.67±13.90) L.h-1.Conclusion The results showed that there was no significant difference in pharmacokinetics compared with the reference which had reported 2-5 .
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To evaluate the safety and pharmacokinetic parameters of a domestic ribavirin tablets in Chinese healthy male volunteers after administered 300 mg oral dosage. Methods Twenty healthy Chinese volunteers were given a single oral dose domestic ribavirin tablet. The concentration of ribavirin in blood plasma was measured by an validated LC-MS/MS method and were assessed with non-compartment model to obtain the pharmacokinetic parameters.Results The pharmacokinetic parameters of ribavirin tablets for orally administered 300 mg dosage were as follows: AUC0-t was(5584.91±1659.34)ng.h.mL-1; AUC0-∞ was(7166.33±2224.28)ng.h.mL-1;Cmax was(442.60±148.97)ng.mL-1;tmax was(1.40±1.20)h;t1/2 was(22.93±6.38)h;Ke was (0.03±0.01) h-1;Vd was (1484.37±491.50);CL was (45.67±13.90) L.h-1.Conclusion The results showed that there was no significant difference in pharmacokinetics compared with the reference which had reported 2-5 .
Key concepts: Pharmacokinetics, Ribavirin, Cmax, Medicine, Pharmacology, Plasma concentration, Virology, Virus